Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
14.23B | 14.04B | 13.32B | 11.60B | 10.45B | 12.49B | Gross Profit |
2.23B | 1.99B | 1.38B | 600.00M | -154.00M | 938.00M | EBIT |
2.17B | 1.91B | 1.29B | 500.00M | -338.00M | 833.00M | EBITDA |
4.46B | 3.13B | 2.46B | 1.73B | 1.22B | 2.12B | Net Income Common Stockholders |
1.95B | 2.09B | 1.22B | 673.00M | -338.00M | 198.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.45B | 1.96B | 1.97B | 1.72B | 2.05B | 994.00M | Total Assets |
23.09B | 23.00B | 21.18B | 20.15B | 20.75B | 20.74B | Total Debt |
6.42B | 7.36B | 7.82B | 8.62B | 9.41B | 9.32B | Net Debt |
3.96B | 5.40B | 5.85B | 6.90B | 7.36B | 8.35B | Total Liabilities |
9.88B | 11.22B | 11.72B | 12.06B | 13.38B | 13.02B | Stockholders Equity |
12.00B | 10.72B | 8.55B | 7.31B | 6.64B | 7.00B |
Cash Flow | Free Cash Flow | ||||
0.00 | -222.00M | 879.00M | 538.00M | 587.00M | 80.00M | Operating Cash Flow |
0.00 | 2.46B | 2.33B | 1.58B | 1.67B | 1.75B | Investing Cash Flow |
0.00 | -1.75B | -1.10B | -975.00M | -754.00M | -1.67B | Financing Cash Flow |
0.00 | -715.00M | -986.00M | -936.00M | 147.00M | -111.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥13.42B | 7.73 | 0.30% | 2.97% | -16.90% | ||
70 Neutral | ¥44.20B | 14.58 | 1.76% | -1.86% | -2.54% | ||
69 Neutral | ¥7.91B | 7.28 | 0.48% | 2.99% | 2.08% | ||
67 Neutral | ¥18.28B | 16.07 | 0.88% | -0.82% | 12.58% | ||
66 Neutral | ¥241.40B | 10.73 | 1.88% | 7.94% | -5.97% | ||
66 Neutral | $4.48B | 12.26 | 5.32% | 248.53% | 4.10% | -12.36% | |
63 Neutral | ¥18.34B | 13.22 | 1.32% | 10.64% | 110.18% |